https://www.selleckchem.com/pr....oducts/biricodar.htm
28), enucleation (P=0.51), and neovascular glaucoma (P=0.4. The 5-year local control rate was 90% (95% confidence interval 76%, 96%) for fSRT and 89% (70%, 97%) for SRS. Our meta-analysis showed no difference in tumor control, survival and toxicities, as defined in this paper, between SRS and fSRT for uveal melanoma. Confounding biases remain an expected limitation in this study of novel treatment modalities deployed in rare tumors. Further investigation is needed to validate outcomes and compare stereotactic treatment techniques. O
Like
Comment
Share
